The neuromuscular disease community received encouraging news this week as Edgewise Therapeutics announced the sale of sevasemten and its Becker and Duchenne muscular dystrophy programs to Servier, a global pharmaceutical company with […]
Tevard Biosciences to present most recent data to Duchenne community for first time at CureDuchenne FUTURES National Conference on May 22 with webinar to follow on May 28 Newport Beach, […]
CureDuchenne recently continued its commitment to improving global standards of care for Duchenne muscular dystrophy by participating in the first Latin American Duchenne Symposium in Santiago, Chile, followed by an […]
Four-Day Conference Will Feature Leading Experts, Inspirational Speakers,and the Latest Care and Treatment Insights Newport Beach, Calif., April 24, 2026 – CureDuchenne, a global nonprofit committed to finding and funding a […]
Emerging guidance offers cautious optimism—here’s what parents and caregivers should know For years, families affected by Duchenne muscular dystrophy have heard a consistent message: “be cautious with exercise, don’t overdo it.” That guidance came from a […]
Renowned Napa Valley Vintners and Philanthropists Unite in Newport Beach for a Weekend of Wine, Food, and Purpose NEWPORT BEACH, California (March 27, 2026) – CureDuchenne, a global leader in advancing research and […]
Expanded Facility Delivers Comprehensive, Multidisciplinary Care, Removing Barriers for Patients with Duchenne and Becker Muscular Dystrophy DALLAS – February 20, 2026 – CureDuchenne, a global leader in advancing research and […]
Free nationwide events deliver expert guidance and meaningful connections for families impacted by Duchenne and Becker muscular dystrophy NEWPORT BEACH, Calif., February 4, 2025 – CureDuchenne, a global leader in advancing research and improving patient […]
Napa’s Finest Come to Newport Beach, Led by Vintner Chair Peter Michael Winery NEWPORT BEACH, California (February 5, 2026) – CureDuchenne, a global leader in accelerating research and care for Duchenne muscular dystrophy, has […]
